Valuation: Sirnaomics Ltd.

Market Cap 54.49M 427M 47.2M 44.63M 40.4M 75.83M 5.23B 76.4M 533M 205M 2.65B 205M 200M 8.45B P/E 2024
-0.67x
P/E 2025 -6.46x
Enterprise Value 50.28M 394M 43.56M 41.19M 37.29M 69.98M 4.82B 70.51M 491M 189M 2.45B 189M 185M 7.8B EV / Sales 2024
24.1x
EV / Sales 2025 -
Free-Float
73.19%
Yield 2024 *
-
Yield 2025 -
1 day-1.15%
1 week+2.65%
Current month+2.92%
1 month-7.62%
3 months-18.83%
6 months-38.51%
Current year-49.41%
1 week 3.63
Extreme 3.63
4
1 month 3.63
Extreme 3.63
4.7
Current year 3.63
Extreme 3.63
10.72
1 year 3.63
Extreme 3.63
17.76
3 years 2.35
Extreme 2.35
54.25
5 years 2.35
Extreme 2.35
101
10 years 2.35
Extreme 2.35
101
Manager TitleAgeSince
Chief Executive Officer 48 2024-11-05
Director of Finance/CFO 35 2021-08-31
Compliance Officer 73 2019-12-31
Director TitleAgeSince
Chairman 48 2025-11-30
Director/Board Member 56 2025-02-16
Director/Board Member 50 2025-07-02
Date Insider Type Main position Quantity % Market Cap. Importance
3/30/26 Other 38,000 0.0354%
11/24/24 Other

Chief Executive Officer

12,067 0.0138%
6/5/24 Other

Executive/Senior Manager

5,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+2.65%-77.66%-92.65% 54.49M
-1.38%+0.20%+46.42%+96.33% 69.18B
-0.72%-1.46%+35.20%+74.64% 62B
-4.29%-3.98%-16.22%+350.66% 26.19B
+1.46%+2.25%+28.84%+14.54% 25.75B
-2.20%-2.00%-1.22%-14.48% 24.29B
+3.09%+4.36%+25.50%-14.44% 19.84B
+1.26%-14.23%+170.04%+298.75% 15.65B
-5.54%+0.69%-8.13%+830.48% 13.88B
-0.39%-4.24%-9.86%+454.94% 14.09B
Average -0.99%-1.86%+19.29%+199.88% 27.09B
Weighted average by Cap. -1.00%-1.32%+31.72%+158.05%

Financials

2024 2025
Net sales 1.78M 13.95M 1.54M 1.46M 1.32M 2.47M 171M 2.49M 17.38M 6.69M 86.48M 6.68M 6.53M 276M -
Net income -51.38M -403M -44.51M -42.09M -38.1M -71.51M -4.93B -72.05M -502M -193M -2.5B -193M -189M -7.97B -14.4M -113M -12.48M -11.8M -10.68M -20.05M -1.38B -20.2M -141M -54.16M -701M -54.1M -52.9M -2.23B
Net Debt -3.71M -29.11M -3.21M -3.04M -2.75M -5.16M -356M -5.2M -36.27M -13.96M -180M -13.94M -13.63M -576M -4.2M -32.98M -3.64M -3.44M -3.12M -5.85M -403M -5.89M -41.09M -15.81M -204M -15.79M -15.44M -652M
Logo Sirnaomics Ltd.
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a multi-targeted siRNA therapeutic advancing clinical development across two oncology indications: squamous cell carcinoma in situ (isSCC) and basal cell carcinoma (BCC). Its STP707 is an intravenous siRNA therapeutic being evaluated in phase I clinical trial for multiple solid tumors, including colorectal, pancreatic, liver, and metastatic melanoma cancers. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.
Employees
-
Date Price Change Volume
26-09-16 HK$3.880 -1.15% 18,700
26-09-15 HK$3.925 -0.38% 9,500
26-09-14 HK$3.940 -1.38% 20,850
26-09-11 HK$3.995 +3.63% 41,100
26-09-10 HK$3.855 +1.98% 19,150
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5004USD
Average target price
9.200USD
Spread / Average Target
+1,738.71%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2257 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!